New FDA coronavirus vaccine rules bring U.S. closer to other countries
Briefly

FDA narrowed approval of coronavirus vaccines to people at higher risk of severe disease and to those 65 and older, bringing U.S. policy closer to many other countries. The change created confusion over eligibility and coincided with resignations by top public health officials who say the Trump administration and Health and Human Services Secretary Robert F. Kennedy Jr. have undermined vaccine science. WHO prioritizes coronavirus vaccines for pregnant, immunocompromised people and the elderly and says revaccination is not routinely recommended for healthy adults or minors. Mexico and Canada largely echo these recommendations, with annual campaigns or targeted groups. Most European countries recommend vaccines for high-risk groups or older age ranges.
Food and Drug Administration decision this week to narrow approval of coronavirus vaccines, once available to nearly all Americans, to those at higher risk of severe disease and to people 65 and older brought U.S. policy closer to that of many other countries. But the changed sparked confusion over who can get shots amid resignations by top public health officials who say the Trump administration and Health and Human Services Secretary Robert F. Kennedy Jr. have undermined vaccine science, a context with far fewer parallels.
It says coronavirus vaccine vaccines are a high priority for pregnant or immunocompromised people and the elderly, while revaccination is "not routinely recommended" for healthy adults or minors. Mexico's vaccination policy largely echoes the WHO recommendations, and the country runs annual vaccination campaigns targeting high-risk individuals. Canada's Health Department recommends coronavirus vaccines to groups including people older than 65, health care workers, pregnant people, and those belonging to Indigenous communities.
Read at The Washington Post
[
|
]